Annual report pursuant to Section 13 and 15(d)

Note 21 - Financial Information About the Parent, the Issuer and the Guarantors (Detail) - Condensed Consolidating Statement Of Cash Flows

v2.4.0.6
Note 21 - Financial Information About the Parent, the Issuer and the Guarantors (Detail) - Condensed Consolidating Statement Of Cash Flows (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2010
Net cash provided by (used in) operating activities $ 37,701,000 $ 63,162,000 $ 51,331,000
Cash flows from investing activities:      
Capital expenditures 22,884,000 9,094,000 9,922,000
Acquisitions 520,000 2,957,000 50,000
Proceeds from the disposal of property, plant and equipment 1,873,000 3,196,000 13,198,000
Change in restricted cash and investments (975,000) (927,000) 17,318,000
Purchase of marketable securities 3,647,000 9,466,000 11,364,000
Proceeds from the sale of marketable securities 7,230,000 7,319,000 200,000
Other (816,000) (432,000) (165,000)
Net cash provided by (used in) investing activities (16,157,000) (9,643,000) (25,091,000)
Payments on long-term debt 12,204,000 37,887,000 42,000
Purchases and other retirements of company stock 1,350,000 5,377,000  
Dividends paid 8,062,000 5,754,000 5,801,000
Net cash provided by (used in) financing activities (20,878,000) (49,079,000) (6,041,000)
Effect of exchange rate changes on cash 536,000 227,000 693,000
Net decrease in cash and cash equivalents 1,202,000 4,667,000 20,892,000
Cash & cash equivalents - beginning of year 78,519,000 73,852,000 52,960,000
Cash & cash equivalents - end of year 79,721,000 78,519,000 73,852,000
Parent Company [Member]
     
Net cash provided by (used in) operating activities 9,187,000 11,055,000 5,800,000
Cash flows from investing activities:      
Purchases and other retirements of company stock (1,350,000) (5,377,000)  
Proceeds from issuance of common stock 225,000 76,000 1,000
Dividends paid (8,062,000) (5,754,000) (5,801,000)
Net cash provided by (used in) financing activities (9,187,000) (11,055,000) (5,800,000)
Subsidiary Issuer [Member]
     
Net cash provided by (used in) operating activities 3,939,000 38,590,000 48,466,000
Cash flows from financing activities:      
Increase in deferred financing costs   (137,000) (199,000)
Cash flows from investing activities:      
Capital expenditures (1,952,000) (1,182,000) (393,000)
Proceeds from the disposal of property, plant and equipment 12,000    
Change in restricted cash and investments 975,000 927,000 (17,318,000)
Purchase of marketable securities (3,647,000) (9,466,000) (11,364,000)
Proceeds from the sale of marketable securities 7,230,000 7,319,000 200,000
Other 305,000 432,000 165,000
Net cash provided by (used in) investing activities 2,923,000 (1,970,000) (28,710,000)
Payments on long-term debt (11,917,000) (33,989,000)  
Excess tax benefits from share-based payment arrangements 238,000    
Net cash provided by (used in) financing activities (11,679,000) (34,126,000) (199,000)
Net decrease in cash and cash equivalents (4,817,000) 2,494,000 19,557,000
Cash & cash equivalents - beginning of year 69,763,000 67,269,000 47,712,000
Cash & cash equivalents - end of year 64,946,000 69,763,000 67,269,000
Guarantor Subsidiaries [Member]
     
Net cash provided by (used in) operating activities 18,441,000 10,672,000 (4,272,000)
Cash flows from investing activities:      
Capital expenditures (15,721,000) (5,017,000) (6,706,000)
Acquisitions (520,000) (2,957,000) (50,000)
Proceeds from the disposal of property, plant and equipment 1,861,000 3,196,000 13,198,000
Other 511,000    
Net cash provided by (used in) investing activities (13,869,000) (4,778,000) 6,442,000
Payments on long-term debt (287,000) (3,898,000) (42,000)
Proceeds from noncontrolling interest 275,000    
Net cash provided by (used in) financing activities (12,000) (3,898,000) (42,000)
Net decrease in cash and cash equivalents 4,560,000 1,996,000 2,128,000
Cash & cash equivalents - beginning of year 7,716,000 5,720,000 3,592,000
Cash & cash equivalents - end of year 12,276,000 7,716,000 5,720,000
Non-Guarantor Subsidiaries [Member]
     
Net cash provided by (used in) operating activities 6,134,000 2,845,000 1,337,000
Cash flows from investing activities:      
Capital expenditures (5,211,000) (2,895,000) (2,823,000)
Net cash provided by (used in) investing activities (5,211,000) (2,895,000) (2,823,000)
Effect of exchange rate changes on cash 536,000 227,000 693,000
Net decrease in cash and cash equivalents 1,459,000 177,000 (793,000)
Cash & cash equivalents - beginning of year 1,040,000 863,000 1,656,000
Cash & cash equivalents - end of year 2,499,000 1,040,000 863,000
Consolidated Entities [Member]
     
Net cash provided by (used in) operating activities 37,701,000 63,162,000 51,331,000
Cash flows from financing activities:      
Increase in deferred financing costs   (137,000) (199,000)
Cash flows from investing activities:      
Capital expenditures (22,884,000) (9,094,000) (9,922,000)
Acquisitions (520,000) (2,957,000) (50,000)
Proceeds from the disposal of property, plant and equipment 1,873,000 3,196,000 13,198,000
Change in restricted cash and investments 975,000 927,000 (17,318,000)
Purchase of marketable securities (3,647,000) (9,466,000) (11,364,000)
Proceeds from the sale of marketable securities 7,230,000 7,319,000 200,000
Other 816,000 432,000 165,000
Net cash provided by (used in) investing activities (16,157,000) (9,643,000) (25,091,000)
Payments on long-term debt (12,204,000) (37,887,000) (42,000)
Purchases and other retirements of company stock (1,350,000) (5,377,000)  
Proceeds from issuance of common stock 225,000 76,000 1,000
Excess tax benefits from share-based payment arrangements 238,000    
Proceeds from noncontrolling interest 275,000    
Dividends paid (8,062,000) (5,754,000) (5,801,000)
Net cash provided by (used in) financing activities (20,878,000) (49,079,000) (6,041,000)
Effect of exchange rate changes on cash 536,000 227,000 693,000
Net decrease in cash and cash equivalents 1,202,000 4,667,000 20,892,000
Cash & cash equivalents - beginning of year 78,519,000 73,852,000 52,960,000
Cash & cash equivalents - end of year $ 79,721,000 $ 78,519,000 $ 73,852,000